STRONGBRIDGE BIOPHARMA plc Interest Expense
STRONGBRIDGE BIOPHARMA plc reported Interest Expense of $810.00 thousand for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-05.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2021-08-05
- STRONGBRIDGE BIOPHARMA plc interest expense for the quarter ending 2021-06-30 was $810.00K, a 220.16% increase year-over-year.
- STRONGBRIDGE BIOPHARMA plc interest expense for the quarter ending 2021-03-31 was $782.00K.
- STRONGBRIDGE BIOPHARMA plc interest expense for the quarter ending 2020-12-31 was $560.00K.
- STRONGBRIDGE BIOPHARMA plc interest expense for the quarter ending 2020-09-30 was $523.00K.
- STRONGBRIDGE BIOPHARMA plc interest expense for fiscal 2020 was $1.34M.
- STRONGBRIDGE BIOPHARMA plc interest expense for fiscal 2018 was $12.52M, a 190.17% increase from fiscal 2017.
- STRONGBRIDGE BIOPHARMA plc interest expense for fiscal 2017 was $4.31M, a 21465.00% increase from fiscal 2016.
- STRONGBRIDGE BIOPHARMA plc interest expense for fiscal 2016 was $20.00K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2021-06-30 | $810.00K 10-Q · filed 2021-08-05 | $1.59M 10-Q · filed 2021-08-05 | $2.15M derived: sum of 3 quarters · filed 2021-08-05 | $2.67M derived: sum of 4 quarters · filed 2021-08-05 |
| 2021-03-31 | $782.00K 10-Q · filed 2021-05-12 | $1.34M derived: sum of 2 quarters · filed 2021-05-12 | $1.86M derived: sum of 3 quarters · filed 2021-05-12 | $2.12M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-12-31 | $560.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03 | $1.08M derived: sum of 2 quarters · filed 2021-03-03 | $1.34M derived: sum of 3 quarters · filed 2021-08-05 | $1.34M 10-K · filed 2021-03-03 |
| 2020-09-30 | $523.00K 10-Q · filed 2020-10-29 | $776.00K derived: sum of 2 quarters · filed 2021-08-05 | $776.00K 10-Q · filed 2020-10-29 | |
| 2020-06-30 | $253.00K 10-Q · filed 2021-08-05 | $253.00K 10-Q · filed 2021-08-05 | ||
| 2018-12-31 | $2.96M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03 | $6.35M derived: sum of 2 quarters · filed 2021-03-03 | $9.64M derived: sum of 3 quarters · filed 2021-03-03 | $12.52M 10-K · filed 2021-03-03 |
| 2018-09-30 | $3.39M 10-Q · filed 2019-11-07 | $6.68M derived: sum of 2 quarters · filed 2019-11-07 | $9.55M 10-Q · filed 2019-11-07 | $11.03M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | $3.29M 10-Q · filed 2019-07-31 | $6.16M 10-Q · filed 2019-07-31 | $7.64M derived: sum of 3 quarters · filed 2020-02-28 | $9.00M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | $2.87M 10-Q · filed 2019-05-01 | $4.35M derived: sum of 2 quarters · filed 2020-02-28 | $5.71M derived: sum of 3 quarters · filed 2020-02-28 | $6.45M derived: sum of 4 quarters · filed 2020-02-28 |
| 2017-12-31 | $1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $2.84M derived: sum of 2 quarters · filed 2020-02-28 | $3.58M derived: sum of 3 quarters · filed 2020-02-28 | $4.31M 10-K · filed 2020-02-28 |
| 2017-09-30 | $1.36M 10-Q · filed 2018-10-31 | $2.10M derived: sum of 2 quarters · filed 2018-10-31 | $2.84M 10-Q · filed 2018-10-31 | |
| 2017-06-30 | $737.00K 10-Q · filed 2018-08-08 | $1.47M 10-Q · filed 2018-08-08 | ||
| 2017-03-31 | $737.00K 10-Q · filed 2018-05-10 | |||
| 2016-12-31 | $20.00K 10-K · filed 2019-02-27 |